Fountain Biopharma Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
PIPE
- Financing Rounds
-
3
- Investments
-
1
Fountain Biopharma General Information
Description
Fountain Biopharma Inc is engaged in the development of antibody drugs in Taiwan. It's pipeline products include antibody drugs for cancer, asthma and allergic diseases, and Chinese hamster ovary cell production. The company is focused on the development of therapeutic monoclonal antibodies and DNA aptamers for cancer and immunological conditions.
Contact Information
Website
www.fountainmab.comCorporate Office
- 19-1, Number 3 Yuan Qu Street
- Nankang District
- Taiepi, 115
- Taiwan
Corporate Office
- 19-1, Number 3 Yuan Qu Street
- Nankang District
- Taiepi, 115
- Taiwan
Fountain Biopharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fountain Biopharma Patents
Fountain Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019085902-A1 | Treating ige-mediated allergic diseases | Inactive | 31-Oct-2017 | ||
| WO-2015145268-A2 | Methods for producing recombinant glycoproteins with modified glycosylation | Inactive | 17-Mar-2014 | ||
| WO-2015145268-A3 | Methods for producing recombinant glycoproteins with modified glycosylation | Inactive | 17-Mar-2014 | ||
| WO-2015145268-A8 | Methods for producing recombinant glycoproteins with modified glycosylation | Inactive | 17-Mar-2014 | ||
| JP-2017507664-A | Process for producing recombinant glycoproteins having modified glycosylation | Active | 17-Mar-2014 | C12P21/005 |
Fountain Biopharma Signals
Fountain Biopharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Fountain Biopharma Acquisitions (1)
Fountain Biopharma’s most recent deal was a Merger/Acquisition with Synovel Sciences. The deal was made on 01-Mar-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Synovel Sciences | 01-Mar-2017 | Merger/Acquisition | Drug Discovery |
Fountain Biopharma FAQs
-
When was Fountain Biopharma founded?
Fountain Biopharma was founded in 2010.
-
Where is Fountain Biopharma headquartered?
Fountain Biopharma is headquartered in Taiepi, Taiwan.
-
What is the size of Fountain Biopharma?
Fountain Biopharma has 39 total employees.
-
What industry is Fountain Biopharma in?
Fountain Biopharma’s primary industry is Drug Discovery.
-
Is Fountain Biopharma a private or public company?
Fountain Biopharma is a Private company.
-
What is Fountain Biopharma’s current revenue?
The current revenue for Fountain Biopharma is .
-
How much funding has Fountain Biopharma raised over time?
Fountain Biopharma has raised $51.5M.
-
Who are Fountain Biopharma’s investors?
Diamond Biofund has invested in Fountain Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process